Associated Papers
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation.
Borenäs M et al.
The Embo Journal, 2021
33411331 (PubMed )
Supplement: EMBJ-40-e105784-s005.xlsx › Table_SNV_SV_combined
Select a paper to view details